vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and REED'S, INC. (REED). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $7.5M, roughly 1.0× REED'S, INC.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -50.5%, a 1.9% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -23.1%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-3.9M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -11.7%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Waddell & Reed Financial, Inc. was an American asset management and financial planning company founded in 1937 in Kansas City, Missouri. It was a publicly traded company from 1998 to 2021, and briefly had its headquarters in Overland Park, Kansas, and was planning a move back to Downtown Kansas City before the company was sold. It operated asset management and distribution subsidiaries, including Ivy Investment Management Company and Waddell & Reed Investment Management Company.

CCEL vs REED — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.0× larger
CCEL
$7.8M
$7.5M
REED
Growing faster (revenue YoY)
CCEL
CCEL
+20.9% gap
CCEL
-2.3%
-23.1%
REED
Higher net margin
CCEL
CCEL
1.9% more per $
CCEL
-48.7%
-50.5%
REED
More free cash flow
CCEL
CCEL
$5.1M more FCF
CCEL
$1.2M
$-3.9M
REED
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-11.7%
REED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
REED
REED
Revenue
$7.8M
$7.5M
Net Profit
$-3.8M
$-3.8M
Gross Margin
77.9%
20.4%
Operating Margin
-50.6%
-46.9%
Net Margin
-48.7%
-50.5%
Revenue YoY
-2.3%
-23.1%
Net Profit YoY
-105.1%
8.2%
EPS (diluted)
$-0.46
$-1.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
REED
REED
Q4 25
$7.8M
$7.5M
Q3 25
$7.8M
$7.0M
Q2 25
$7.9M
$9.5M
Q1 25
$8.0M
$10.0M
Q4 24
$8.0M
$9.7M
Q3 24
$8.1M
$6.8M
Q2 24
$8.0M
$11.9M
Q1 24
$7.9M
$9.6M
Net Profit
CCEL
CCEL
REED
REED
Q4 25
$-3.8M
$-3.8M
Q3 25
$749.4K
$-4.0M
Q2 25
$355.8K
$-6.0M
Q1 25
$282.9K
$-2.0M
Q4 24
$-1.9M
$-4.1M
Q3 24
$1.1M
$-4.2M
Q2 24
$655.8K
$-3.2M
Q1 24
$556.2K
$-1.7M
Gross Margin
CCEL
CCEL
REED
REED
Q4 25
77.9%
20.4%
Q3 25
77.0%
17.4%
Q2 25
76.6%
8.5%
Q1 25
75.1%
33.9%
Q4 24
78.4%
30.0%
Q3 24
73.6%
18.0%
Q2 24
74.8%
32.3%
Q1 24
73.7%
35.6%
Operating Margin
CCEL
CCEL
REED
REED
Q4 25
-50.6%
-46.9%
Q3 25
24.3%
-58.3%
Q2 25
18.8%
-60.8%
Q1 25
13.3%
-17.4%
Q4 24
-1.5%
-37.6%
Q3 24
17.2%
-46.5%
Q2 24
17.3%
-5.6%
Q1 24
10.5%
-6.8%
Net Margin
CCEL
CCEL
REED
REED
Q4 25
-48.7%
-50.5%
Q3 25
9.6%
-56.6%
Q2 25
4.5%
-63.5%
Q1 25
3.5%
-20.3%
Q4 24
-23.2%
-42.3%
Q3 24
13.0%
-61.5%
Q2 24
8.2%
-27.1%
Q1 24
7.1%
-17.4%
EPS (diluted)
CCEL
CCEL
REED
REED
Q4 25
$-0.46
$-1.26
Q3 25
$0.09
$-0.48
Q2 25
$0.04
$-0.13
Q1 25
$0.03
$-0.04
Q4 24
$-0.23
$-3.73
Q3 24
$0.13
$-4.91
Q2 24
$0.08
$-0.77
Q1 24
$0.07
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
REED
REED
Cash + ST InvestmentsLiquidity on hand
$3.3M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$9.2M
Total Assets
$61.7M
$23.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
REED
REED
Q4 25
$3.3M
Q3 25
$3.2M
Q2 25
$4.4M
Q1 25
$3.5M
Q4 24
$3.5M
Q3 24
$2.1M
Q2 24
$1.5M
Q1 24
$979.6K
Total Debt
CCEL
CCEL
REED
REED
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
REED
REED
Q4 25
$-18.6M
$9.2M
Q3 25
$-14.8M
$2.8M
Q2 25
$-15.6M
$1.7M
Q1 25
$-14.7M
$4.7M
Q4 24
$-13.2M
$6.6M
Q3 24
$-9.6M
$-22.0M
Q2 24
$-10.7M
$-23.8M
Q1 24
$-10.3M
$-20.7M
Total Assets
CCEL
CCEL
REED
REED
Q4 25
$61.7M
$23.3M
Q3 25
$63.2M
$19.9M
Q2 25
$64.4M
$23.7M
Q1 25
$64.4M
$24.5M
Q4 24
$64.7M
$25.1M
Q3 24
$62.9M
$15.0M
Q2 24
$62.6M
$18.7M
Q1 24
$61.7M
$19.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
REED
REED
Operating Cash FlowLast quarter
$1.3M
$-3.8M
Free Cash FlowOCF − Capex
$1.2M
$-3.9M
FCF MarginFCF / Revenue
15.5%
-52.0%
Capex IntensityCapex / Revenue
0.9%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$-17.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
REED
REED
Q4 25
$1.3M
$-3.8M
Q3 25
$2.5M
$-2.8M
Q2 25
$707.0K
$-5.0M
Q1 25
$954.1K
$-5.4M
Q4 24
$2.2M
$-3.9M
Q3 24
$2.4M
$1.1M
Q2 24
$1.8M
$-912.0K
Q1 24
$-356.9K
$-2.4M
Free Cash Flow
CCEL
CCEL
REED
REED
Q4 25
$1.2M
$-3.9M
Q3 25
$2.5M
$-2.9M
Q2 25
$644.6K
$-5.1M
Q1 25
$892.0K
$-5.4M
Q4 24
$2.1M
$-4.0M
Q3 24
$2.3M
$1.0M
Q2 24
$21.5K
$-924.0K
Q1 24
$-814.6K
$-2.4M
FCF Margin
CCEL
CCEL
REED
REED
Q4 25
15.5%
-52.0%
Q3 25
31.9%
-41.5%
Q2 25
8.1%
-53.2%
Q1 25
11.2%
-54.2%
Q4 24
26.8%
-40.8%
Q3 24
27.9%
15.3%
Q2 24
0.3%
-7.8%
Q1 24
-10.4%
-25.1%
Capex Intensity
CCEL
CCEL
REED
REED
Q4 25
0.9%
1.1%
Q3 25
0.5%
1.4%
Q2 25
0.8%
0.2%
Q1 25
0.8%
0.7%
Q4 24
0.1%
1.0%
Q3 24
2.3%
0.3%
Q2 24
21.8%
0.1%
Q1 24
5.8%
0.2%
Cash Conversion
CCEL
CCEL
REED
REED
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons